Results 151 to 160 of about 3,241 (183)

Durable outcomes with manageable safety leading to prolonged survival with tagraxofusp for treatment-naïve patients with blastic plasmacytoid dendritic cell neoplasm: real world results from a European Named Patient Program. [PDF]

Ann Hematol
Herling M, Angelucci E, Benoit TM, Rivoli G, Curti A, Götze KS, Wirths S, Erakli D, Zuurman M, Deconinck E.   +9 more
europepmc   +1 more source

Spontaneous Remission of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report. [PDF]

Medicina (Kaunas)
Castaño-Bonilla T, Mata R, Láinez-González D, Gonzalo R, Castañón S, Díaz de la Pinta FJ, Blas C, López-Lorenzo JL, Alonso-Domínguez JM.   +8 more
europepmc   +1 more source

Nodal Mature Plasmacytoid Dendritic Cell Proliferation in a Patient With Chronic Myelomonocytic Leukemia: A Diagnostic Mimic of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

J Investig Med High Impact Case Rep
Al-Nusair J, Porter N, Alagha Z, Graffeo V, Mahmud W, Alshal M.   +5 more
europepmc   +1 more source

A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients. [PDF]

Ther Adv Hematol
Gong C, Liu Y, Zhang M.
europepmc   +1 more source

Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [PDF]

, 2017
Dreyling, M., Dummer, R.
core  

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights from Countries of the Gulf Cooperation Council. [PDF]

Cancers (Basel)
Bakshi N, Al Hejazi A, Al-Maghraby H, Al Mugairi A, Alotaibi AS, Khogeer H, Seliem RM, Pandita R, Raslan H, Aung PP, Ohgami RS.   +10 more
europepmc   +1 more source

Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report. [PDF]

Oncol Lett
Luo F, Li B, Li J, Li Y.
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm with Periorbital Ecchymosis and Massive Subconjunctival Hemorrhage as a Presenting Sign: A Case Report. [PDF]

Korean J Ophthalmol
Wang LL, Kim N.
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Rare Entity in Clinical Practice. [PDF]

Cureus
Oliveira B, Nogueira C, Dias L, Ribeiro T, Gomes G.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Blastic Plasmacytoid Dendritic Cell Neoplasm

Journal of the National Comprehensive Cancer Network, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with an aggressive clinical course and poor prognosis. BPDCN is most often characterized by its presentation with distinct cutaneous lesions. Bone marrow involvement, lymphadenopathy, splenomegaly, and/or cytopenias are also seen to varying degrees.
Akriti, Jain, Kendra, Sweet
  +5 more sources